Capitol Health Limited

Level 2, 288 Victoria Parade East Melbourne VIC 3002 All correspondence to: PO Box 551 East Melbourne VIC 8002 Email:investors@capitolhealth.com.auTel: (03) 9348 3333

www.capitolhealth.com.au

ABN 84 117 391 812

For personal use only

ASX ANNOUNCEMENT

16 November 2021

AGM - Chair's Address and Managing Director / CEO's Presentation

Capitol Health Limited (Capitol or the Company) (ASX: CAJ) will be holding its Annual General Meeting on 16 November 2021 at 11.00am (AEDT).

The Chair's address and the Managing Director / CEO's presentation for the Annual General Meeting are attached.

For further information, please contact: Craig Bremner

Chief Financial Officer (03)9348 3333 investors@capitolhealth.com.au

About Capitol Health

Capitol Health is a leading provider of diagnostic imaging and related services to the Australian healthcare market. Headquartered in Melbourne, Victoria, the Company owns and operates clinics throughout Victoria, Tasmania, South Australia, and Western Australia. The Company's operational focus is on delivering a community-based infrastructure for radiologists and related medical practitioners to deliver optimal, efficient, accurate healthcare service outcomes for patients.

Capitol also has an investment in diagnostic imaging artificial intelligence through Enlitic Inc in the US.

For personal use only

Capitol Health Limited - 2021 Annual General Meeting - CHAIR ADDRESS

Ladies and gentlemen, I would now like to make some brief remarks to you as Chair of the Company.

The COVID-19 pandemic continues to present very challenging conditions for the Company, and we are very proud that we were able to maintain the highest quality of care and safety for our patients, and that of our staff during this time. The Group received JobKeeper assistance employer subsidy amounting to net $5.8m during FY21, which helped the Company in continuing to retain all staff and to fund the business during various lockdowns. Despite the uncertainty of these unprecedented health and economic impacts that we are still experiencing, the Company has performed very well during this period.

Some of the key financial highlights were:

  • Revenue of $178.0m.
  • Operating EBITDA of $48.0m.
  • Profit after tax of $12.0m.
  • Earnings per share of 1.17 cents.
  • The Group's balance sheet remains sound with cash of $21.7m and unused funding facilities of $110.8m.
  • Fully franked dividends declared in FY21 totalling 1.0 cent per share.

We are pleased to see that everyone's effort in building, reinforcing, and implementing procedures and measures to safeguard the Company's assets are coming to fruition. During FY21, as part of its strategic plan to grow organically and expand its network of high-quality community imaging centres, the Company acquired Direct Radiology. Direct Radiology has three state of the art clinics offering comprehensive diagnostic imaging services located in Fairfield, Monbulk, and South Melbourne. As outlined in our previous reports, the Company continues to protect the safety of our valued staff and patients.

We also listen to our stakeholders and engage actively with them through our roadshows. As requested by our valued shareholders, we have built on the capabilities of our Board through the appointment of Ms Laura McBain and Dr Kevin Shaw. Ms McBain has vast experience and knowledge

of the business and finance arena, while Dr Shaw has expertise and knowledge of the medical imaging industry. The Board would like to thank Ms Nicole Sheffield for her contributions to

the Company's performance and good governance since her appointment in December 2015 and we wish her well in her future endeavours.

I am also taking this opportunity to inform our shareholders that should my re-election as a director be approved at this meeting, 2024 would mark my 10th year as a Director of the Company. After my re-election at this meeting, the Board will work on a succession and transition plan to ensure that my successor is well equipped to lead the Board.

On behalf of the Board, I would like to thank our radiologists and staff for their continued efforts and commitment to outstanding patient care particularly in these continued challenging times; our patients who used our services and the large group of referrers who continue to support our clinics. The Board would also like to sincerely thank our Managing Director and CEO, Justin Walter, and his management team for their commitment to the Company and for successfully navigating the business during challenging times. I would also like to thank my fellow Board members for their contribution to the Company. Lastly, I thank you, the shareholders of Capitol Health, for your continued support of the Company.

Annual General Meeting

16 November 2021

onlyMANAGING DIRECTOR / CEO'S ADDRESS useersonal

AGENDA

1.

CEO FY21 Summary

useonly

FY21 Financials

2.

3.

CEO FY22 Business Update

ersonal

2

1. CEO FY21 Summary

ersonal use only

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Capitol Health Limited published this content on 15 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2021 21:51:26 UTC.